Aquinnah Pharmaceuticals

United States · 16 Employees

Aquinnah Pharmaceuticals is focused on a new area of research and development to modulate neurodegenerative stress granules, believed to be important in the pathology of amyotrophic lateral sclerosis (ALS), Alzheimer's disease and other neurodegenerative diseases. The medical need for ALS is very high as there are currently no effective treatments for this devastating neurodegenerative disease. ALS progresses rapidly, eventually affecting muscles in the arms, legs, face, diaphragm, and chest. Today, approximately 60% of patients with ALS will not survive beyond three years following diagnosis, with 10% of new patients surviving at least 10 years. Aquinnah Pharmaceuticals has identified lead molecules advancing to clinical studies which are designed to prevent and potentially reverse the pathological stress granules in affected patients. In addition to their use in ALS, these compounds also show promise as a potential treatment for cognition impairment in patients with Alzheimer's disease and other neurodegenerative diseases. New work published in Nature Neuroscience by co-founder Ben Wolozin, M.D.,Ph.D., has implicated stress granule disease progression with tau; which is a neuronal pathologic protein that correlates with Alzheimer's disease progression. Aquinnah is pioneering new approaches to identify small molecule drugs that modulate intracellular tau-stress granule biology, representing a new first in class treatment for Alzheimer's disease and other tauopathy diseases.

查看员工

概述

国家	United States
成立时间	2014
总部	610 main street, cambridge, massachusetts, united states
电话号码	+1 (617) 863-3678
网站	http://www.aquinnahpharma.com
LinkedIn	http://www.linkedin.com/company/aquinnah-pharmaceuticals
Twitter	https://twitter.com/aquinnahpharma
Facebook
员工数	16
行业	research,
简介	A BOLD NEW APPROACH TO NEURODEGENERATIVE DISEASE - ALS and Alzheimer’s

查看更多信息

技术

Amazon AWS

Hosting

Google Analytics

Analytics and Tracking

Google Tag Manager

Tag Management

Microsoft Office 365

Other

Mobile Friendly

Other

Outlook

Email Providers

Typekit

Fonts

YouTube

Online Video Platforms

查看所有技术

常见问题

Aquinnah Pharmaceuticals 在哪里?

Aquinnah Pharmaceuticals 的总部位于 610 main street, cambridge, massachusetts, united states

Aquinnah Pharmaceuticals 的电话号码是多少?

Aquinnah Pharmaceuticals 的电话号码是 +1 (617) 863-3678

Aquinnah Pharmaceuticals 的官方网站是什么?

Aquinnah Pharmaceuticals 的公司官方网站是 http://www.aquinnahpharma.com

Aquinnah Pharmaceuticals 是做什么的?

A BOLD NEW APPROACH TO NEURODEGENERATIVE DISEASE - ALS and Alzheimer’s

Aquinnah Pharmaceuticals 的业务有哪些?

Aquinnah Pharmaceuticals 的年收入是多少?

Aquinnah Pharmaceuticals 的收入是 3000000美元

Aquinnah Pharmaceuticals 有多少员工?

Aquinnah Pharmaceuticals 有 16 名员工

Aquinnah Pharmaceuticals 属于哪个行业?

Aquinnah Pharmaceuticals 从事以下行业: research

Aquinnah Pharmaceuticals 使用什么技术?

Aquinnah Pharmaceuticals 使用的一些流行技术包括: Amazon AWS,Google Analytics,Google Tag Manager,Microsoft Office 365,Mobile Friendly,Outlook,Typekit,YouTube

如何联系 Aquinnah Pharmaceuticals?

Aquinnah Pharmaceuticals 联系信息: 电话号码:+1 (617) 863-3678，网站:http://www.aquinnahpharma.com，邮箱：abe***@***.com

Aquinnah Pharmaceuticals 的社交媒体链接是什么?

Aquinnah Pharmaceuticals 领英：http://www.linkedin.com/company/aquinnah-pharmaceuticals,fackbook：,twitte:https://twitter.com/aquinnahpharma

Aquinnah Pharmaceuticals 是一家上市公司吗?

不是

Aquinnah Pharmaceuticals 的最后一轮融资是什么时候?

Aquinnah Pharmaceuticals在2019-01-17T00:00:00.000+00:00结束了最后一轮融资,金额达750K$。

谁投资 Aquinnah Pharmaceuticals?

Aquinnah Pharmaceuticals 有 5 家投资者,包括 Alzheimer's Association, Tau Consortium、、Pfizer, AbbVie Inc.、Takeda Pharmaceuticals、National institutes of Neurological Disorders and Stroke。

See More Information

管理层

寻找更多决策者

寻找更多员工

外贸获客查找关键决策人

10亿+海关交易数据，1.2亿企业数据，2亿+企业联系人数据，1000千万真实采购商。覆盖200+个国家及地区，95%外贸重点拓展市场，可根据行业、经营范围等多方位挖掘目标客户。

免费试用

Top-ranked on G2 Crowd

全球B2B企业库海关贸易数据展会采购数据

贸易数据国家覆盖范围

AI数据库

样本数据搜索

资源中心

合作共赢

了解